One more time, emphasizing the advantage of simultaneous pancreas and kidney transplantation for patients with type 1 diabetes and end-stage renal disease.

Abstract

Simultaneous pancreas and kidney (SPK) transplantation is considered the best treatment option for patients with diabetes and end-stage renal disease (ESRD). SPK recipients with a functioning pancreas graft have significantly better kidney graft survival and patient survival compared to those who received a kidney-only transplant or those with a failed pancreas graft. In addition, SPK recipients with isolated pancreas graft failure who undergo pancreas retransplant still have better kidney graft survival.